Stoke Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of STOK for the last quarter is 4.22 M USD, and it's 50.46% higher compared to the previous quarter. The net income of Q1 24 is -26.37 M USD.